Motilal Oswal

What should your equity, fixed income portfolio look like? Motilal answers

MOPW reiterates their view to have a duration bias in the fixed income portfolio so as to capitalize on the likely softening of yields in the next 1-2 years

Go green to women only: Mutual funds set to differentiate in FY24

HDFC MF, Motilal Oswal and Samco among fund houses offering new plans

Motilal Oswal AMC introduces new features in SWP; calls it 'FAB' plan

At the heart of this offering is the company's vision to give investors more control when planning their long-term financial goals and lifestyle choices

Motilal Oswal arm announced to invests Rs 400 crore in Pan Heathcare

A Motilal Oswal arm on Tuesday announced a Rs 400 crore investment in Rajkot-based hygiene products maker Pan Healthcare for a minority stake. The company established in 2016, which manufactures diapers and sanitary napkins, will use the funds for brand building and ramping up distribution, its promoter Chirag Pan said in a statement. Funds managed by or advised by Motilal Oswal Alternate Investment Advisors (MO Alts) have invested in the company of Pan Group, which also has interest in cement, cotton, steel and agri-trading, the statement said. Vijay Dhanuka, head of consumer sector at MO Alts said the hygiene products segment in India is significantly underpenetrated as reflected by per capita diaper consumption of less than 60 units as against 1,000 in the US and 400 in China, and the market is dominated by multinational companies. The company's strategy of creating large-scale operations, be it in manufacturing or in offline distribution through large feet-on-street workforce,

Clients went overboard on equities in last two years, says Ashish Shanker

Don't get carried away by near-term point-to-point returns as it will often lead to losses, says the Motilal Oswal Private Wealth MD & CEO

At 4% of GDP, household financial savings touch 30-year low; consumption up

In FY22, savings stood at 7.3 per cent. This fall in savings indicates an increase in consumption

Adani firms, RIL share honours in Motilal Oswal wealth-creation study

The biggest wealth creator in absolute terms is Mukesh Ambani-led Reliance Industries, with an increase in market capitalisation of Rs 13 trillion between 2017 and 2022

NSEL scam: Sebi bans five major commodity brokers for six months

The brokers had appealed to the Securities Appellate Tribunal (SAT) against a previous order by Sebi issued in 2019

Motilal Oswal invests Rs 450 cr in Shapoorji Pallonji Real Estate

Takes exposure to two projects--one commercial, the other a residential township

Easing material costs to aid Pidilite margins, near-term pressures weigh

Upsides from current levels may be capped due to higher valuations

Motilal Oswal AMC to accept fresh investments in international schemes

The AMC had suspended fresh subscriptions to these schemes in Jan after the MF industry came close to breaching global investment limit

Share of low-cost deposits falls as FD rates rise, banks' NIM may take hit

With RBI on monetary tightening path, liquidity has shrunk and interest rates have hardened, forcing banks to hike rates on term deposits in order to get funds for credit growth

Brokerages see margin expansion at auto firms as outlook turns positive

Higher volumes and softer raw materials to drive expansion

Smartworld Developers expect sales worth Rs 250 cr from retail project

The 100,000 sw ft project in Gurugram is spread over three floors, with units ranging from 500 sq ft to 12,000 sq ft

IPO watch: DCX issue subscribed nearly 70 times on strong QIB interest

Price band set at Rs 197-207; No institutional takers for Fusion microfinance on opening day

Strong US pipeline, sustained growth trajectory main trigger for Dr Reddy's

Excluding the strong US show led by Revlimid, Q2 was a mixed bag

Strong retail interest sees DCX Systems IPO subscribed 2.19 times on day-1

Price band set at Rs 197-207 a share; retail portion sold 8.7x

Uncertainty on revenue growth, margin outlook hits Gland Pharma stock

The injectable manufacturing company expects the margin pressure to persist due to cost pressures and negative operating leverage.

Motilal Oswal invests Rs 260 cr in 3 projects of Urbanrise-Alliance Group

The total saleable area in these three projects would extent to 6.2 million square feet and is expected generate a revenue of Rs 4,600 crore

Piramal Pharma ends at Rs 192 on debut, valued at Rs 22,882 cr at close

Domestic brokerage Motilal Oswal has set a price target of Rs 210 for the stock